HLHIX Mutual Fund

HLHIX Mutual Fund

NAV$32.22

Fund Essentials - as of Mar 31, 2026

Net Assets
$5M
Expense Ratio
1.05%
Dividend Yield (Current)
-
Holdings
24
Inception Date
Dec 22, 2014
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD-2.94%
1 Year+9.69%
3 Year+1.18%
5 Year+5.60%
10 Year+9.38%

Asset Allocation

Stocks: 100.00%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company13.30%
MCKMckesson Corp.15.57%
ABBVAbbvie Inc Health Care5.09%
VRTXVertex Pharmaceuticals Inc5.09%
MRKMerck & Co. Inc.5.05%
Top 10 Concentration: 55.84%Report Date: Mar 31, 2026
Download all 24 holdings for HLHIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$7.49
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how HLHIX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

HLHIX Mutual Fund Overview

HLHIX Mutual Fund (Virtus KAR Health Sciences Fund Institutional Class) is managed by Virtus Investment Partners with $5.1M in net assets. HLHIX expense ratio is 1.05%, holding 24 positions across sectors including Health Care, Consumer Staples. Inception date: 2014-12-22.

HLHIX performance shows a YTD return of -2.94%. The 1-year return is 9.69% and the 5-year return is 5.60%.

HLHIX top holdings include Eli Lilly And Company (13.3%), Mckesson Corp.1 (5.6%), Abbvie Inc Health Care (5.1%), Vertex Pharmaceuticals Inc (5.1%), Merck & Co. Inc. (5.0%). Go to all HLHIX holdings, HLHIX sectors, or HLHIX dividends.

HLHIX can be compared against other funds. Use HLHIX overlap to find shared positions, or HLHIX vs another fund for a side-by-side view. HLHIX alternatives are available via the screener, along with tax-loss harvesting opportunities.